This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Luye Innomind Pharma Shijiazhuang Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Dawei Yu - Innovator in VMAT2 Inhibition
Introduction
Dawei Yu is a prominent inventor based in Yantai, China. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that inhibit VMAT2. His innovative work has the potential to impact the treatment of various diseases related to this target.
Latest Patents
Dawei Yu holds a patent for a VMAT2 inhibitor and its preparation method. The patent describes a class of compounds that serve as VMAT2 inhibitors, specifically focusing on a compound represented by formula (I), or its stereoisomers or pharmaceutically acceptable salts. This invention also details the use of these compounds in the preparation of medicaments aimed at treating diseases associated with VMAT2.
Career Highlights
Dawei Yu is currently associated with Luye Innomind Pharma Shijiazhuang Co., Ltd. His work at this company has allowed him to further his research and development efforts in the pharmaceutical industry. His dedication to innovation is evident in his patent and ongoing projects.
Collaborations
Dawei Yu collaborates with notable colleagues, including Jingwei Tian and Liang Ye. Their combined expertise enhances the research and development efforts within their organization.
Conclusion
Dawei Yu's contributions to the field of VMAT2 inhibition exemplify the importance of innovation in medicine. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.